Effectiveness of Drainage by PCN vs. JJ in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

204 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-07-15

Study Completion Date

2024-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To investigate the effectiveness of percutaneous nephrostomy catheter placement versus retrograde double J catheter placement in patients with symptoms of obstructive kidney disease (with either infection and/or pain and/or kidney function deterioration) caused by urolithiasis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Ureteral Stenting After Retrograde Intrarenal Surgery for Renal Stones

NCT05738304

Kidney Stone Retrograde Intrarenal Surgery Ureteral Stent

UNKNOWN NA

Ureteral Stents Versus Percutaneous Nephrostomy for Initial Urinary Drainage

NCT02055430

Children Obstructive Uropathy Acute Renal Failure +1 more

COMPLETED NA

Ureteral Stent Versus Percutaneous Nephrostomy in Acutely Obstructed Infected Kidney

NCT03498794

Management of Obstructed Infected Kidney

COMPLETED NA

Clinical Outcomes of Percutaneous Nephrolithotomy Following Retrograde Percutaneous Nephrostomy Access Using Novel Device in Comparison to Antegrade Access

NCT05022537

Kidney Stone

NOT_YET_RECRUITING NA

Percutaneous Nephrolithotomy Without a Ureteral Catheter

NCT05598671

Nephrolithotomy Percutaneous Kidney Calculi

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

SUMMARY Rationale If a stone obstructs the ureter and impairs urine-efflux from the kidney this may cause infection, pain resulting from a renal colic and/or renal impairment. Drainage of the kidney may be necessary and can be established by placement of either a percutaneous nephrostomy (PCN) or a retrograde double J catheter (JJ). Considering method of drainage, setting, room in which drainage procedures takes place and anesthesia method, there are in fact 16 different approaches for drainage available, each with its own consequences for the patient and on expenses. Although evidence is poor, both methods of drainage are to be considered as equal.\[1\] This is reflected by the differences in preference between different countries.\[2\] In 2016 the Dutch association for urology (Nederlandse Vereniging voor Urologie (NVU)) marked this subject as one of the primary knowledge gaps in urology in The Netherlands and gave it priority on the national knowledge agenda for urology.\[3\] From patients' as well as from societal perspective it is of importance that the decision for placement of either PCN or JJ will be made based on evidence based arguments and in a uniform way.

Hypothesis: Percutaneous nephrostomy is non inferior to retrograde double J catheter regarding time to clinical recovery. Secondly, patient reported outcome measures (PROMS) comparing treatment room and OR settings of drainage procedures will most likely not be significantly different.

Finally, because percutaneous nephrostomy catheters are more often placed in a (outpatient) urological or radiological treatment room, this is expected to be less expensive than placement of a double J catheter (more often placed in the OR). Objective: To investigate the effectiveness of percutaneous nephrostomy catheter placement versus retrograde double J catheter placement in patients with symptoms of obstructive kidney disease (with either infection and/or pain and/or kidney function deterioration) caused by urolithiasis.

Study design: Multicenter prospective randomized controlled non-inferiority trial.

Study population: Male and female adult patients with signs of obstructive kidney disease with kidney or ureteral lithiasis as an underlying cause and with an indication for drainage based on symptoms of or laboratory tests indicating infection and/or pain and/or kidney function.

Intervention: One group receives drainage by percutaneous nephrostomy catheter placement as opposed to the other group which will receive drainage by retrograde double J catheter placement.

Main study parameters/endpoints:

The primary objective is to assess whether a PCN is non-inferior to double J catheter regarding time to clinical recovery in patients with obstructive kidney disease resulting from urolithiasis.

The primary outcome parameter is time to clinical recovery. Clinical recovery is defined as reaching one or more of the following criteria. The mandatory amount of criteria to achieve clinical recovery is dependent on the indication for placement of a PCN or a JJ.

* If indication for drainage is infection: improvement of infection, indicated by a decrease of WBC in two executive laboratory results and below 15.000 mm3 and a body temperature of 36-38.5 C. and/or
* If indication for drainage is untreatable pain: Numeric rating score (NRS) considering pain resulting from a renal colic is improved and \< 3 points and/or
* If indication for drainage is deterioration of kidney function: improvement of creatinine/ Glomerular Filtration Rate (GFR) in two executive laboratory results It may occur that the indication for drainage is a combination of the above named indications. Clinical recovery will then be reached in case all parameters related to the different indications are within the set range. Secondary outcomes are further clinical data, PROMS (measured by the EQ-5D-5L, NRS, a satisfaction scale and a catheter questionnaire) and societal costs (measured by a diseasespecified iMCQ questionnaire).

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: The placement of either PCN or double J catheter is standard care. Currently the choice for PCN or a double J catheter is based on expert opinion and may be driven by arguments considering logistics or assumptions about the quality of life for a patient after placement.

Considering the difference in rate of placement of both PCN and double J catheter between various hospitals and different countries, it is believed experts have no uniform work method to handle the dilemma of choosing between these two techniques.\[2\] Furthermore the current EAU-guideline 2018 states that both methods of drainage are to be considered as equal.\[1\] Therefore there is no reason to believe, patients will be affected negatively by being placed randomly in either the double J group or the PCN group. Questionnaires will be filled in daily during hospitalization and twice or less afterwards. This is not considered to be a risk for the patient. The longest questionnaires (EQ-5D-5L and iMCQ) will take approximately 10-20 minutes to fill in, additional to the shorter scales (NRS, satisfaction scale) which will take approximately 1 minute to fill in. Generally It will take 90 minutes, spread over the course of three months, to fill in all questionnaires. For frequency and timing of the questionnaires. Finally, no additional visits to a hospital, withdrawal of blood samples or exposure to radiation is to be expected when taking part in this study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urolithiasis Urologic Diseases Urinary Calculi Urinary Obstruction Urinary Stone Ureteric Obstruction Calculus Ureteral Stone Ureter Stone;Renal Stone, Kidney Stone, Urinary Obstruction Ureter Obstruction Ureter Calculi Ureter Obstruction Kidney Diseases Kidney Calculi Kidney Failure, Acute Kidney Dysfunction Kidney Insufficiency Pyelonephritis Pyelonephritis Acute Pyelonephritis Obstructive Pyelonephritis; Calculus Pyelonephritis; Obstruction Pyelonephrosis Hydronephrosis Hydronephrosis; Infection Hydronephrosis, Infected Hydronephrosis; Obstruction, Ureter Hydronephrosis; Obstruction, Renal Calculus Hydronephrosis, Secondary Renal Pelvis; Obstruction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomised controlled trial

Primary Study Purpose

OTHER

Blinding Strategy

NONE

No masking is possible because stent is visible to patient and physician

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Percutaneous Nephrostomy

drainage of the kidney by means of a percutaneous Nephrostomy

Group Type ACTIVE_COMPARATOR

Percutaneous Nephrostomy

Intervention Type DEVICE

A Percutaneous Nephrostomy will be placed in patients with obstructive urolithiasis

Double J catheter

drainage of the kidney by means of a double J catheter

Group Type ACTIVE_COMPARATOR

Double J catheter

Intervention Type DEVICE

A Double J catheter will be placed in patients with obstructive urolithiasis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Percutaneous Nephrostomy

A Percutaneous Nephrostomy will be placed in patients with obstructive urolithiasis

Intervention Type DEVICE

Double J catheter

A Double J catheter will be placed in patients with obstructive urolithiasis

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

PCN Nephrostomies, Percutaneous Percutaneous Nephrostomies Nephrostomy stent JJ internal stent JJ catheter urinary stent internal urinary stent ureteral stent internal ureteral stent internal ureteric stent ureteric stent ureteral stents internal ureteral stents internal ureteric stents ureteric stents double j ureteral catheter double-j catheter internalized double-j catheter

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- In order to be considered eligible to participate in this study, a subject must meet all of the following criteria:

* Male/female \>18 year
* Symptoms and/or laboratory results indicating obstructive kidney disease with or without infection.
* A kidney or ureteral stone is present on ultrasound or CT (max 3 months old prior to presentation)
* Both drainage techniques are feasible and safe in opinion of the treating physician (from logistics point of view and in the best interest of the patient).
* Willing and able to comply with filling in questionnaires and follow-up regiment

Exclusion Criteria

A potential subject who meets any of the following criteria will be excluded from participation in this study:

* Analphabetic or not mastering the Dutch language
* Pregnancy
* Usage of anticoagulation agents other than acetylsalicylic acid.
* Contraindication for either technique looking at history and anatomy (e.g. kidney transplant, pouch, Bricker deviation, urethral or ureteral stenosis)

Eligible Sex

ALL

Accepts Healthy Volunteers

No